The BioPharma sector is under constant pressure to bring more novel therapies to market, more quickly and affordably. Attaining this goal requires improved operational control and continuous real-time ...
T cell lymphocytes play a central role in the adaptive immune response. They are an essential tool of adoptive cell therapy for the treatment of chronic viral infections and malignant diseases.